Get an alert when MSD R&D INNOVATION CENTRE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-10-04 (in 5mo)

Last made up 2025-09-20

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£31M

+83.3% vs 2023

Employees

169

+20.7% vs 2023

Profit before tax

£5M

-6.6% vs 2023

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £50,243,000£52,973,000
Operating profit £5,611,000£415,000
Profit before tax £5,380,000£5,023,000
Net profit £3,554,000£2,270,000
Cash £182,000
Total assets less current liabilities £18,226,000£33,907,000
Net assets £17,129,000£31,399,000
Equity £17,129,000£31,399,000
Average employees 140169
Wages £17,193,000£18,994,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 11.2%0.8%
Net margin 7.1%4.3%
Return on capital employed 30.8%1.2%
Current ratio 1.32x1.47x
Interest cover 23.68x0.74x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have prepared the financial statements on a going concern basis. Before confirming the appropriateness of the going concern basis of preparation, the Directors reviewed and considered the following: The relative strength of the MSD Group's and the Company's balance sheets in this context. The level of cash held by the Group and access to further third-party debt. On 19 December 2024 MSD R&D Innovation Centre Limited issued Merck Sharp & Dohme Research GmbH. with 1 share at a premium, as detailed in Note 15. This provided sufficient investment to sustain a net asset position and provided sufficient cash to meet the entities expenditure needs for the period ending 31 December 2024 and the forecast expenditure requirements for the period ending 31 December 2025. The directors continue to monitor the funding needs of the company and have obtained written confirmation from their immediate parent company Merck Sharp & Dohme Research GmbH., confirming support to enable the company to meet its liabilities when they fall due for a period of at least 12 months from the date of the approval of the financial statements. The company, therefore, continues to adopt the going concern basis in preparing its financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 27 resigned

Name Role Appointed Born Nationality
LUCAS, Benjamin Paul Director 2022-02-01 Nov 1974 British
RICHARDSON, Jill Caroline, Dr Director 2023-10-06 Sep 1966 British
TEMUCIN, Ebru Can Director 2017-06-23 Oct 1972 Turkish
Show 27 resigned officers
Name Role Appointed Resigned
DALBY, Marc Charles Secretary 2007-01-19
DAVIES, Amy Secretary 2020-11-23 2022-05-03
MCARDLE, Kevin Edward Secretary 2007-04-04 2011-06-30
ROBINSKI, Richard Secretary 2011-06-28 2020-11-23
ANSTICE, David Westbrook Director 1993-05-21 1994-10-04
ARMITAGE, Robert Director 2003-09-19 2012-03-23
ARMITAGE, Robert John Director 1993-12-10 2001-01-01
BELL, Graeme Director 2009-06-23 2009-11-05
BOUSFIELD, Keith Director 2012-03-23 2014-12-31
CLIFFE, Christopher Frederick Director 1993-03-31
HOUSON, Louise Jane Director 2016-09-06 2019-10-01
JACKSON, James Russell Director 2001-01-01 2003-05-31
KHANNA, Deepak Kumar Director 2009-11-04 2014-06-30
KLIMCZAK, Steven Robert Director 1994-11-01 2000-10-01
LAWTON, Vincent Michael Director 2006-06-28
LEONARD, Melissa Director 2013-12-11 2016-10-15
LEWENT, Judy Carol Director 2007-08-14
LITCHFIELD, Caroline Ann Director 2003-06-25 2009-06-23
MCDOWELL, Mark Andrew Charles Director 2009-11-04 2013-12-31
MORAN, Michael Craig Director 2021-07-06 2023-10-06
NALLY, Michael Thomas Director 2014-06-30 2016-09-30
NICHOLSON, Simon Director 2014-12-31 2021-07-06
PEACOCK, David Director 2019-10-01 2022-02-01
POLZ, Gertraud Director 2016-09-06 2017-06-23
ROUND, Christopher Director 2006-07-13 2009-11-06
SPIEGEL, Francis Herman Director 1994-09-29
WHITE, Katherine Elizabeth Director 2014-12-31 2016-03-18

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Merck & Co., Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 191 total filings

Date Type Category Description
2025-12-22 AA accounts Accounts with accounts type full
2025-09-22 CS01 confirmation-statement Confirmation statement with updates PDF
2024-12-23 SH01 capital Capital allotment shares PDF
2024-09-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-09-19 AA accounts Accounts with accounts type full
2023-10-24 AP01 officers Appoint person director company with name date PDF
2023-10-09 TM01 officers Termination director company with name termination date PDF
2023-10-06 AA accounts Accounts with accounts type full
2023-09-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-09-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-08-19 AA accounts Accounts with accounts type full
2022-06-07 PSC05 persons-with-significant-control Change to a person with significant control PDF
2022-05-03 TM02 officers Termination secretary company with name termination date PDF
2022-02-02 AP01 officers Appoint person director company with name date PDF
2022-02-01 TM01 officers Termination director company with name termination date PDF
2021-10-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-09-20 AP01 officers Appoint person director company with name date PDF
2021-09-02 AA accounts Accounts with accounts type full
2021-07-07 TM01 officers Termination director company with name termination date PDF
2021-01-14 AD01 address Change registered office address company with date old address new address PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
1

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page